EUVIMEDEUVIMED entdecken
Open Access

Serologic Immunity to Tetanus in the United States, National Health and Nutrition Examination Survey, 2015–2016

Valerie D Bampoe iD, Nicole Brown, Li Deng, Jarad Schiffer, Lily Tao Jia, Monica Epperson, Yamini Gorantla, So Hee Park, Jingning Ao, Anna M Acosta, Susan Hariri

Clinical Infectious Diseases · 17.02.2024 · 78 (2) · 470-475

DOI: 10.1093/cid/ciad598 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Clinical Infectious Diseases, online erschienen am 03.10.2023. Verfasst von Valerie D Bampoe und 10 weiteren Autor:innen. Beteiligte Einrichtung: Meningitis and Vaccine Preventable Diseases Branch, Division of Bacterial Diseases, National Center for Immunization and Respiratory Diseases, Center…. Hauptthemen laut MEDLINE: Tetanus. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 31 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: Intramural CDC HHS, CDC HHS, Centers for Disease Control and Prevention.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Tetanus, a life-threatening infection, has become rare in the United States since introduction of tetanus toxoid-containing vaccines (TTCVs), recommended as a childhood series followed by decennial boosters beginning at age 11–12 years; vaccination uptake is high in children but suboptimal in adults. The objective of this study was to estimate the prevalence of sero-immunity to tetanus among persons aged ≥6 years in the United States and to identify factors associated with tetanus sero-immunity. Understanding population protection against tetanus informs current and future vaccine recommendations.

Methods

Anti-tetanus toxoid antibody concentrations were measured for participants of the 2015–2016 National Health and Nutrition Examination Survey (NHANES) aged ≥6 years for whom surplus serum samples were available using a microsphere-based multiplex antibody capture assay. Prevalence of sero-immunity, defined as ≥0.10 IU/mL, was estimated overall and by demographic characteristics. Factors associated with tetanus sero-immunity were examined using multivariable regression.

Results

Overall, 93.8% of the US population aged ≥6 years had sero-protection against tetanus. Prevalence of sero-immunity was above 90% across racial/ethnic categories, sex, and poverty levels. By age, ≥ 90% had protective sero-immunity through age 69 years, but prevalence of sero-immunity declined thereafter, with 75.8% of those aged ≥80 years having protective sero-immunity. Older age (adjusted prevalence ratio [aPR]: 0.89, 95% confidence interval [CI]: .85–.92) and being born outside the United States (aPR: 0.96, 95% CI: .93–.98) were significantly associated with lower prevalence of sero-immunity.

Conclusions

The majority of the US population has vaccine-induced sero-immunity to tetanus, demonstrating the success of the vaccination program.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

TetanusAdultChildHumansUnited StatesAgedNutrition SurveysTetanus ToxoidVaccinationImmunization, SecondaryAntibodies, Bacterial

Stichwörter der Autor:innen

ELISAMMACAmicrosphere-based multiplex antibody capture assaynational health and nutrition and examination survey (NHANES)tetanus sero-immunity

Substanzen

Tetanus ToxoidAntibodies, Bacterial

Autor:innen und Institutionen

  • Meningitis and Vaccine Preventable Diseases Branch, Division of Bacterial Diseases, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.
  • Epidemic Intelligence Service, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.
  • Microbial Pathogenesis and Immune Response Laboratory, Division of Bacterial Diseases, National Center of Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.

ORCID-Profile: Valerie D Bampoe

Förderung

  • Intramural CDC HHS
  • CDC HHS
  • Centers for Disease Control and Prevention

Zitieren

APA

Bampoe, V. D., Brown, N., Deng, L., Schiffer, J., Jia, L. T., Epperson, M., Gorantla, Y., Park, S. H., Ao, J., Acosta, A. M., & Hariri, S. (2024). Serologic Immunity to Tetanus in the United States, National Health and Nutrition Examination Survey, 2015–2016. Clinical Infectious Diseases, 78(2), 470-475. https://doi.org/10.1093/cid/ciad598

Vancouver

Bampoe VD, Brown N, Deng L, Schiffer J, Jia LT, Epperson M, et al. Serologic Immunity to Tetanus in the United States, National Health and Nutrition Examination Survey, 2015–2016. Clinical Infectious Diseases. 2024;78(2):470-475. doi:10.1093/cid/ciad598

BibTeX
@article{Bampoe2024,
  author = {Bampoe, Valerie D and Brown, Nicole and Deng, Li and Schiffer, Jarad and Jia, Lily Tao and Epperson, Monica and Gorantla, Yamini and Park, So Hee and Ao, Jingning and Acosta, Anna M and Hariri, Susan},
  title = {Serologic Immunity to Tetanus in the United States, National Health and Nutrition Examination Survey, 2015–2016},
  journal = {Clinical Infectious Diseases},
  year = {2024},
  volume = {78},
  number = {2},
  pages = {470--475},
  doi = {10.1093/cid/ciad598}
}
Kostenlos starten →